Therefore, the current study aimed to assess the potential utility of tissue lncRNA-H19 expression and circulating miR-675 as a non-invasive biomarker for potential HCC diagnosis and prognosis, as well as assessing changes in EGFR, VEGF, and cyclin D1 levels in hepatic tissue. The gene discussed is CCND1; the disease is hepatocellular carcinoma.